(secondQuint)FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent.

 This is a single center, non-randomized study of the Bx VELOCITY Balloon-Expandable Stent coated with sirolimus (140 mu g/cm2) and formulated for fast or slow release.

 The sirolimus coated stent is mounted on the Raptor OTW SDS.

 Approximately 30 patients with de novo or restenotic native coronary artery lesions =3.

0 to >=3.

5 mm in diameter by visual estimate who meet all eligibility criteria will be treated with the sirolimus coated Bx VELOCITY stent(s).

 Patients will be followed for five years post-procedure and will have a repeat angiography at 4 months, 12 months, 24 months, and 48 months.

.

 FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent@highlight

This is a single center, non-randomized study.

 Patients will be treated with the sirolimus coated Bx VELOCITY Balloon-Expandable Stent mounted on the Raptor OTW SDS.

 Patients will have a repeat angiography at four months and will be followed for twelve months post-procedure.

